Inactive Instrument

EVIO, Inc. Stock Other OTC

EVIO

US30051V1061

EVIO, Inc. is a diversified holding company. The Company provides analytical testing services to the agricultural and pharmaceutical industries, primarily for cannabis, hemp, and related products. The Company offers residential and commercial construction services. The Company also offers research and development and consulting services for participants in the cannabis and hemp industries. The Company tests products to verify the regulatory requirements for sale. Its subsidiaries include Smith Scientific Industries, LLC; Greenhaus Analytical Labs, LLC; Viridis Analytics, LLC; EVIO Labs OR, Inc.; C3 Labs, LLC; EVIO Labs Humboldt, LLC and Keystone Labs, Inc.

Employees

Sector

Business Support Services

More about the company

As early as today, start finding the best investment opportunities!

Market Cap	1.66M 1.47M 1.39M 1.26M 2.36M 159M 2.38M 16.63M 6.41M 81.36M 6.23M 6.1M 262M	P/E 2020	-0.08x	P/E 2021	-1.33x
Enterprise Value	14.32M 12.64M 11.96M 10.85M 20.33M 1.37B 20.53M 143M 55.29M 702M 53.78M 52.61M 2.26B	EV / Sales 2020	4.41x	EV / Sales 2021	6.54x
Free-Float	88.19%	Yield 2020 *	-	Yield 2021	-

11/03/22	DigiPath, Inc. cancelled the acquisition of a controlling stake in C3 Labs, LLC from EVIO, Inc..	CI
04/01/22	EVIO, Inc. Announces Partnership with Rare Earth Genomics Texas, LLC	CI
07/12/21	DigiPath, Inc. signed letter of intent to acquire a controlling stake in C3 Labs, LLC from EVIO, Inc..	CI
11/11/21	Framework announced that it has received $2 million in funding from EVIO, Inc., Atomico Investment Holdings Limited, Ada Ventures Limited, Learn Capital, LLC, and other investors	CI
02/11/21	EVIO, Inc. Announces Diversification into Blockchain	CI
12/07/21	EVIO, Inc. entered into a letter of intent to acquire Leading Edge Pharms, Inc.	CI
04/02/21	EVIO, Inc. announced that it has received $0.157 million in funding	CI
05/01/21	EVIO, Inc. Announces Executive Changes	CI
05/01/21	EVIO, Inc. Announces Executive Changes	CI
30/09/20	Steep Hill, Inc. completed the acquisition of unknown minority stake in C3 Labs, LLC from EVIO, Inc..	CI
09/09/20	Evio, Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2020	CI
11/07/20	EVIO, Inc. Announces Executive Changes	CI
06/07/20	Steep Hill Labs, Inc. entered into non-binding Letter of Intent to acquire 49% stake in C3 Labs, LLC from EVIO, Inc..	CI

04/01/22	EVIO, Inc. Announces Partnership with Rare Earth Genomics Texas, LLC	PR
29/11/21	EVIO, Inc. Announces Major Blockchain Partnership with Chroma Signet	PR
02/11/21	EVIO, Inc. Announces Diversification into Blockchain	PR
15/10/21	EVIO, Inc :. provides Shareholder Update	PR
31/08/21	EVIO : Files Form 15 to Suspend SEC Reporting Requirements and Applies to Qualify for OTC Markets Alternative Reporting Standard for Pink Sheet Companies	PR

Manager	Title	Age	Since
William Waldrop CEO	Chief Executive Officer	58	-
Lori Glauser CEO	Chief Executive Officer	56	01/01/2021
Jeremy L. Sackett CTO	Chief Tech/Sci/R&D Officer	-	13/05/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
EVIO, INC.	-3.45%	-6.67%	-	-	20.73K
SGS SA	+0.25%	-0.13%	+16.49%	+24.55%	22.36B
UL SOLUTIONS INC.	+0.15%	-2.29%	-6.68%	-	13.08B
CENTRE TESTING INTERNATIONAL GROUP CO. LTD.	-1.23%	-7.23%	+7.08%	-27.14%	3.45B
HEFEI CHIPMORE TECHNOLOGY CO.,LTD.	+3.17%	-7.98%	+36.04%	+46.43%	3.11B
TIC SOLUTIONS, INC.	-3.09%	-8.34%	-40.67%	-	1.91B
CHINA AUTOMOTIVE ENGINEERING RESEARCH INSTITUTE CO., LTD.	+0.39%	+0.15%	-26.63%	-35.65%	1.94B
GRG METROLOGY & TEST GROUP CO., LTD.	-2.00%	+2.62%	-5.46%	+18.46%	1.65B
EMTEK (SHENZHEN) CO., LTD.	+2.05%	-3.61%	+81.18%	+115.18%	1.52B
CHINA NATIONAL ELECTRIC APPARATUS RESEARCH INSTITUTE CO., LTD.	+0.69%	-0.95%	-26.64%	+6.08%	1.3B
Average	-0.48%	-2.92%	+3.86%	+21.13%	5.59B
Weighted average by Cap.	-0.42%	-2.17%	+7.31%	+21.05%

EVIO, Inc. Stock Other OTC

Stocks

EVIO

US30051V1061

Business Support Services

Valuation: EVIO, Inc.

Latest news: EVIO, Inc.

Press Releases: EVIO, Inc.

Quotes and Performance

Managers and Directors: EVIO, Inc.

Testing Laboratories

Financials

Company Profile

	2020	2021
Net sales	3.6M 3.17M 3M 2.72M 5.11M 345M 5.16M 36.02M 13.88M 176M 13.5M 13.21M 567M	2.36M 2.09M 1.97M 1.79M 3.35M 227M 3.39M 23.67M 9.12M 116M 8.87M 8.68M 373M
Net income	-8.42M -7.43M -7.03M -6.37M -11.95M -808M -12.07M -84.3M -32.49M -412M -31.6M -30.91M -1.33B	-965K -852K -806K -731K -1.37M -92.6M -1.38M -9.67M -3.73M -47.28M -3.62M -3.54M -152M
Net Debt	14.79M 13.05M 12.35M 11.2M 21M 1.42B 21.21M 148M 57.1M 725M 55.54M 54.33M 2.33B	12.66M 11.17M 10.57M 9.59M 17.98M 1.22B 18.15M 127M 48.88M 620M 47.55M 46.51M 2B